LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | R406 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3694 | 3694 | 1.0002 | 1.0003 |
| SK-BR-3 | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2106 | 3694 | 0.5701 | 0.2838 |
| SK-BR-3 | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2989 | 3694 | 0.8092 | 0.6822 |
| SK-BR-3 | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 1476 | 1327 | 3694 | 0.3593 | -0.0674 |
| SK-BR-3 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2965 | 3694 | 0.8028 | 0.6715 |
| SK-BR-3 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3161 | 3694 | 0.8557 | 0.7596 |
| SK-BR-3 | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 1425 | 3694 | 0.3859 | -0.0232 |
| SK-BR-3 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2171 | 3694 | 0.5878 | 0.3133 |
| SK-BR-3 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2967 | 3694 | 0.8033 | 0.6723 |
| SK-BR-3 | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3841 | 3694 | 1.0400 | 1.0666 |
| SK-BR-3 | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2715 | 3694 | 0.7352 | 0.5588 |
| SK-BR-3 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2887 | 3694 | 0.7816 | 0.6362 |
| SK-BR-3 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 1526 | 3694 | 0.4131 | 0.0222 |
| SK-BR-3 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3871 | 3694 | 1.0480 | 1.0800 |
| SK-BR-3 | Mitoxantrone | 0.12 | uM | LJP6 | 72 | hr | 1476 | 1531 | 3694 | 0.4146 | 0.0248 |
| SK-BR-3 | MK2206 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2946 | 3694 | 0.7977 | 0.6629 |
| SK-BR-3 | Nintedanib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3786 | 3694 | 1.0251 | 1.0418 |
| SK-BR-3 | NVP-TAE684 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2822 | 3694 | 0.7641 | 0.6070 |
| SK-BR-3 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2997 | 3694 | 0.8115 | 0.6859 |
| SK-BR-3 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3553 | 3694 | 0.9620 | 0.9367 |
| SK-BR-3 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 4293 | 3694 | 1.1621 | 1.2701 |
| SK-BR-3 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 3704 | 3694 | 1.0028 | 1.0046 |
| SK-BR-3 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 1583 | 3694 | 0.4287 | 0.0482 |
| SK-BR-3 | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2683 | 3694 | 0.7263 | 0.5440 |
| SK-BR-3 | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1476 | 2124 | 3694 | 0.5752 | 0.2922 |